ABSTRACT
Disintegrins are small peptides isolated from the venom of several snake families which act as integrin-antagonists or agonists, interacting with a variety of biological processes mediated by integrins. In this work we describe five new disintegrin-like domains within metalloproteinase precursor sequences, obtained from a Bothrops jararaca venom gland cDNA library. Among the new disintegrin-like domains, four were contained in PIII metalloproteinase precursors, with three of them presenting ECD-motifs and one presenting a new KCD-motif. Moreover, we found three disintegrin-like domains within PII metalloproteinase precursors. Two of them are similar to the already described disintegrins jarastatin and jararacin. The third molecule is unusual, presenting some typical PIII metalloproteinase characteristics but lacking the cysteine-rich domain being, thus, classified as a PII metalloproteinase. Only few reports presented molecules with these characteristics. Sequence analysis suggests that these molecules are intermediate steps between the more ancient PIII and the more recent PII metalloproteinases. We also investigated disintegrin N-terminus diversity in B. jararaca crude venom by purifying jarastatin and jararacin and analyzing them by mass spectrometry.
Subject(s)
Bothrops/physiology , Crotalid Venoms/genetics , Disintegrins/genetics , Enzyme Precursors/genetics , Genetic Variation , Metalloproteases/genetics , Amino Acid Sequence , Animals , Catalytic Domain/genetics , Crotalid Venoms/chemistry , Crotalid Venoms/enzymology , DNA, Complementary/genetics , Disintegrins/chemistry , Disintegrins/isolation & purification , Enzyme Precursors/metabolism , Metalloproteases/metabolism , Molecular Sequence Data , Phylogeny , Sequence Alignment , Species Specificity , Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization , Structure-Activity RelationshipABSTRACT
Bothrops jararaca is a pit viper responsible for the majority of snake envenoming accidents in Brazil. As an attempt to describe the transcriptional activity of the venom gland, ESTs of a cDNA library constructed from B. jararaca venom gland were generated and submitted to bioinformatics analysis. The results showed a clear predominance of transcripts coding for toxins instead of transcripts coding for proteins involved in cellular functions. Among toxins, the most frequent transcripts were from metalloproteinases (52.6%), followed by serine-proteinases (28.5%), C-type lectins (8.3%) and bradykinin-potentiating peptides (BPPs) (6.2%). Results were similar to that obtained from the transcriptome analysis of B. insularis, a phylogenetically close sister of B. jararaca, though some differences were observed and are pointed out, such as a higher amount of the hypotensive BPPs in B. insularis transcriptome (19.7%). Another striking difference observed is that PIII and PII-classes of metalloproteinases are similarly represented in B. jararaca in contrast to B. insularis, in which a predominance of PIII-class metalloproteinase, which present a more intense hemorrhagic action, is observed. These features may, in part, explain the higher potency of B. insularis venom. The results obtained can help in proteome studies, and the clones can be used to directly probe the genetic material from other snake species or to investigate differences in gene expression pattern in response to factors such as diet, aging and geographic localization.
Subject(s)
Bothrops/metabolism , Crotalid Venoms/biosynthesis , Gene Expression Profiling , Animals , Gene Library , Lectins, C-Type/genetics , Metalloproteases/genetics , Phylogeny , Serine Endopeptidases/genetics , Teprotide/metabolismABSTRACT
Cholinesterases (ChEs) are highly efficient biocatalysts whose active site is buried in a deep, narrow gorge. The talent of CE to discover inhibitors in the gorge of highly purified preparations has fairly altered the meaning of a ChE ligand-free status. To attempt at a description of this one, we investigated the stability of Bungarus fasciatus acetylcholinesterase (AChE), alone or complexed with different inhibitors. Determination of mid-transition temperature for thermal denaturation, using differential scanning calorimetry (DSC) and CE, provided conflicting results. Discrepancies strongly question the reality of a ligand-free AChE state. DSC allowed estimation of the stability of AChE-ligands complexes, and to rank the stabilizing effect of different inhibitors. CE acted as a detector of hidden ligands, provided that they were charged, reversibly bound, and thus dissociable upon action of electric fields. Then, CE allowed quantification of the stability of ligand-free AChE. CE and DSC providing each fractional and nonredundant information, cautious attention must be paid for actual estimation of the conformational stability of ChEs. Because inhibitors used in purification of ChEs by affinity chromatography are charged, CE remains a leading method to estimate enzyme stability and detect the presence of bound hidden ligands.
Subject(s)
Acetylcholinesterase/chemistry , Bungarus/metabolism , Cholinesterase Inhibitors/chemistry , Models, Molecular , Animals , Binding Sites , Calorimetry, Differential Scanning , Electrophoresis, Capillary , Ligands , ThermodynamicsABSTRACT
Bothrops snake venoms contain metalloproteinases that contribute to the local effects seen after envenoming. In this work, a hemorrhagic metalloproteinase (BlaH1) was purified from the venom of the snake Bothrops lanceolatus by a combination of gel filtration, affinity (metal chelating) and hydrophobic interaction chromatographies. The hemorrhagin was homogeneous by SDS-PAGE and had a molecular mass of 28 kDa that was unaltered by treatment with beta-mercaptoethanol. BlaH1 gave a single band in immunoelectrophoresis and immunoblotting using commercial bothropic antivenom. BlaH1 had hemorrhagic, caseinolytic, fibrinogenolytic, collagenolytic and elastinolytic activities, but no phospholipase A(2) activity. The hemorrhagic and caseinolytic activities were inhibited by EDTA, indicating that they were metal ion-dependent. In contrast, aprotinin, benzamidine and PMSF did not affect these activities. The caseinolytic activity of BlaH1 had a pH optimum of 8.0 and was stable in solution at up to 40 degrees C; activity was completely lost at > or =70 degrees C. The hemorrhagic activity was neutralized by commercial bothropic antivenom. These properties suggest that this new hemorrhagin belongs to class P-I snake venom metalloproteinases.
Subject(s)
Bothrops , Crotalid Venoms/isolation & purification , Metalloendopeptidases/isolation & purification , Animals , Aprotinin/metabolism , Benzamidines/metabolism , Caseins/metabolism , Chromatography, Affinity , Chromatography, Gel , Collagenases/metabolism , Crotalid Venoms/chemistry , Crotalid Venoms/metabolism , Edetic Acid/metabolism , Electrophoresis, Polyacrylamide Gel , Endopeptidases/metabolism , Esterases/metabolism , Fibrinogen/metabolism , Immunoblotting , Male , Metalloendopeptidases/chemistry , Metalloendopeptidases/metabolism , Phospholipases A/metabolism , Rats , Rats, Wistar , TemperatureABSTRACT
The improvement of the immunotherapeutic treatment of envenomations requires a better knowledge of the pharmacological actions of the scorpion venom and of the mechanism of its in vivo neutralization by antivenom. In the present work, we determined the toxicokinetic parameters of the toxic fraction of Androctonus australis garzonii venom in the absence and after antivenom immunotherapy, in experimentally envenomed rabbits. After subcutaneous injection of the scorpion venom, toxins showed a fast and complete resorption from the site of injection associated with a simultaneous distribution in a large extracellular compartment and with an important body clearance. The precocious intravenous injection of an appropriate antivenom dose was shown to induce an immediate, complete and durable neutralization of toxins, as well as their rapid redistribution from the peripheric compartment to the vascular one. On the contrary, the intramuscular injection of the same antivenom dose produced a slower and partial redistribution of toxins, leading to a delayed neutralization of the venom. The intravenous injection of smaller antivenom doses induced transient decreases of circulating toxins, indicating that a minimal antivenom dose has to be administered to allow an efficient and durable neutralization of the venom. We concluded also that this minimal effective dose of antivenom has to be injected precociously, by intravenous route, to achieve an efficient immunotherapy.
Subject(s)
Antivenins/pharmacology , Scorpion Venoms/pharmacokinetics , Animals , Injections, Intramuscular , Injections, Intravenous , Injections, Subcutaneous , Male , Mice , Rabbits , Scorpion Venoms/immunology , Time FactorsABSTRACT
An epidemiological and biological survey of scorpion envenomation was conducted in Algeria. Analysis of 182 medical files showed that 70% of the patients were stung by Androctonus australis. Most accidents occurred during the morning (40%) or the evening (30%). Two-thirds of the patients reached a hospital 1 hour after being stung. Their clinical symptoms classified 78% of them as Grade I (mild envenomation) and 17% of them as Grade II (moderate envenomation) on admission to hospital. No severe envenomation (Grade III) was reported. Most patients were treated with antivenom by the intramuscular route. Blood samples were collected before and after antivenom immunotherapy. A good correlation was observed between the grade of envenomation on admission and the blood venom concentrations measured by ELISA. The venom concentration decreased as function of the interval between the sting and blood collection (t1/2 = 2 h). Intramuscular injection of 10 ml of antivenom did not efficiently neutralize scorpion venom. Inflammation was followed by measuring IL6 concentration. IL6 peaked 1 h after scorpion envenomation. This study shows that optimization of the administration of antivenom is required to achieve clinical efficiency. In particular, intravenous injection of a larger dose of a more potent antivenom should be considered.
Subject(s)
Immunotherapy/methods , Scorpion Venoms/poisoning , Spider Bites/epidemiology , Adolescent , Adult , Aged , Aged, 80 and over , Algeria/epidemiology , Child , Child, Preschool , Enzyme-Linked Immunosorbent Assay/methods , Female , Humans , Infant , Interleukin-6/blood , Male , Middle Aged , Prospective Studies , Spider Bites/blood , Spider Bites/therapyABSTRACT
Snake venoms contain a number of proteins that interact with components of the haemostatic system that promote or inhibit events leading to blood-clot formation. The snake-venom protein convulxin (Cvx) binds glycoprotein (GP) VI, the platelet receptor for collagen, and triggers signal transduction. Here, the 2.7 A resolution crystal structure of Cvx is presented. In common with other members of this snake-venom protein family, Cvx is an alphabeta-heterodimer and conforms to the C-type lectin-fold topology. Comparison with other family members allows a set of Cvx residues that form a concave surface to be putatively implicated in GPVI binding. Unlike other family members, with the exception of flavocetin-A (FL-A), Cvx forms an (alphabeta)(4) tetramer. This oligomeric structure is consistent with Cvx clustering GPVI molecules on the surface of platelets and as a result promoting signal transduction activity. The Cvx structure and the location of the putative binding sites suggest a model for this multimeric signalling assembly.
Subject(s)
Crotalid Venoms/chemistry , Crotalus , Lectins, C-Type/chemistry , Amino Acid Sequence , Animals , Crystallography, X-Ray , Models, Molecular , Molecular Sequence Data , Platelet Membrane Glycoproteins/metabolism , Sequence AlignmentABSTRACT
The venoms of Viperidae snakes contain numerous serine proteinases that have been recognized to possess one or more of the essential activities of thrombin on fibrinogen and platelets. Among them, a platelet proaggregant protein, cerastocytin, has been isolated from the venom of the Tunisian viper Cerastes cerastes. Using the RACE-PCR technique, we isolated and identified the complete nucleotide sequence of a cDNA serine proteinase precursor. The recombinant protein was designated rCC-PPP (for C. cerastes platelet proaggregant protein), since its deduced amino acid sequence is more than 96% identical to the partial polypeptide sequences that have been determined for natural cerastocytin. The structure of the rCC-PPP cDNA is similar to that of snake venom serine proteinases. The expression of rCC-PPP in Escherichia coli system allowed, for the first time, the preparation and purification of an active protein from snake venom with platelet proaggregant and fibrinogenolytic activities. Purified rCC-PPP efficiently activates blood platelets at nanomolar (8 nM) concentrations, as do natural cerastocytin (5 nM) and thrombin (1 nM). It is able to clot purified fibrinogen and to hydrolyze alpha-chains. Thus, rCC-PPP could be therefore considered a cerastocytin isoform. By comparison with other snake venom serine proteinases, a Gly replaces the conserved Cys(42). This implies that rCC-PPP lacks the conserved Cys(42)-Cys(58) disulfide bridge. A structural analysis performed by molecular modeling indicated that the segment of residues Tyr(67)-Arg(80) of rCC-PPP corresponds to anion-binding exosite 1 of thrombin that is involved in its capacity to induce platelet aggregation. Furthermore, the surface of the rCC-PPP molecule is characterized by a hydrophobic pocket, comprising the 90 loop (Phe(90)-Val(99)), Tyr(172), and Trp(215) residues, which might be involved in the fibrinogen clotting activity of rCC-PPP.
Subject(s)
Platelet Aggregation/drug effects , Serine Endopeptidases/metabolism , Serine Endopeptidases/pharmacology , Viper Venoms/enzymology , Viperidae/metabolism , Amino Acid Sequence , Animals , Base Sequence , Cloning, Molecular , DNA, Complementary/genetics , Fibrinogen/metabolism , Fibrinolysis , Kinetics , Models, Molecular , Molecular Sequence Data , Rabbits , Recombinant Proteins/genetics , Recombinant Proteins/metabolism , Recombinant Proteins/pharmacology , Sequence Homology, Amino Acid , Serine Endopeptidases/chemistry , Serine Endopeptidases/genetics , Thrombin/metabolism , Thrombin/pharmacology , Viperidae/geneticsABSTRACT
Crotoxin, a potent neurotoxin from the South American rattlesnake Crotalus durissus terrificus, is a heterodimeric phospholipase A(2) (EC 3.1.1.4), which blocks the release of acetylcholine from peripheral neurons. We previously have suggested the existence of a 48 kDa crotoxin-binding protein in the presynaptic membranes of the electric organ of Torpedo marmorata. Here, we report the purification and characterization of this protein that we called the crotoxin acceptor protein from Torpedo (CAPT). The membranes of electric organs from Torpedo were solubilized with a detergent (4% (w/v) Triton X-100) and CAPT was isolated by affinity chromatography on a crotoxin column. SDS-PAGE showed that the purified protein was homogeneous and cross-linking studies with radioiodinated crotoxin confirmed that it had retained its toxin-binding properties. The purified CAPT has similar molecular mass as crocalbin, a crotoxin-binding protein isolated from porcine brains, yet anti-crocalbin antiserum failed to recognize CAPT. Surface plasmon resonance biosensor technology was used to measure the specific interaction between crotoxin and solubilized CAPT. Using this method, it was possible to follow CAPT throughout the purification procedure. As well, an apparent dissociation constant (K(d)(app)) of 3.4 nM was calculated for the interaction of pure CAPT and crotoxin from the dissociation rate constant (k(off)=1.2 x 10(-2)s(-1)) and the association rate constant (k(on)=3.5 x 10(6)M(-1)s(-1)).
Subject(s)
Crotoxin/metabolism , Electric Organ/chemistry , Receptors, Cell Surface/isolation & purification , Receptors, Cell Surface/metabolism , Surface Plasmon Resonance , Torpedo , Animals , Crotalus , Protein Binding , Receptors, Cell Surface/chemistry , Synaptic Membranes/metabolismABSTRACT
The ability of Bothrops lanceolatus venom to induce neutrophil migration into the peritoneal cavity of mice was investigated. Intraperitoneal injection of venom caused dose- and time-dependent neutrophil migration, which peaked with 750 ng of venom/cavity 4h after venom injection. The neutrophil migration was significantly reduced by pretreatment with dexamethasone (0.5 mg/kg, s.c.), an indirect inhibitor of phospholipase A(2) (PLA(2)), and AA861 (0.01 mg/kg, s.c.), a 5-lipoxygenase inhibitor, but in contrast, was not modified by pretreatment with indomethacin (2 mg/kg, s.c.), an inhibitor of the cyclooxygenase pathway, meloxicam (5 mg/kg, s.c.), an inhibitor of the cyclooxygenase-2 pathway, or the PAF inhibitor WEB2086 (40 mg/kg, s.c.). Dexamethasone and AA861 also inhibited the neutrophil migration by 60% when administered immediately after venom injection, and the coadministration of these two drugs caused a 75% reduction in migration. BLV-induced neutrophil migration was not due to contamination by endotoxin since polymyxin B-treated venom retained its activity. Heating the venom (97 degrees C, 2 min) reduced the PLA(2) activity by 64% and this was accompanied by a corresponding reduction (68%) in neutrophil migration. These results suggest that arachidonate-derived lipoxygenase metabolites (possibly leukotriene B(4)) are involved in the chemotaxis observed. Macrophages may be an important source of these metabolites since the migratory response to venom was potentiated in mice pretreated with thioglycollate, but reduced when the peritoneal cavity was washed with sterile saline.
Subject(s)
Bothrops , Crotalid Venoms/toxicity , Neutrophils/drug effects , Animals , Azepines/pharmacology , Benzoquinones/pharmacology , Cell Migration Inhibition , Crotalid Venoms/administration & dosage , Dexamethasone/pharmacology , Dose-Response Relationship, Drug , Indomethacin/pharmacology , Injections, Intraperitoneal , Macrophages/drug effects , Male , Mice , Mice, Inbred BALB C , Phospholipases A/metabolism , Triazoles/pharmacologyABSTRACT
A protein capable of inducing neuromuscular blockade in avian preparations and of depolarizing mouse diaphragm muscle was isolated from Bothrops lanceolatus venom using gel filtration and ion-exchange chromatography. The purified protein was a single chain polypeptide with an estimated molecular mass of 27.5 kDa by SDS-PAGE and had caseinolytic activity (13.3 units/mg), but no phospholipase A(2). B.lanceolatus venom (50 micro g/ml) and the caseinolytic protein (20 micro g/ml) produced contracture and progressive irreversible blockade (50% in 25+/-5 min (SEM) and 45+/-15 min, respectively), in indirectly stimulated chick biventer cervicis preparations. The contractile responses to acetylcholine (ACh; 37 and 74 micro M, n=6) were inhibited by venom and the caseinolytic protein, whereas those to potassium (13.4mM, n=6) were not. Membrane resting potential measurements in mouse hemidiaphragm preparations showed that B.lanceolatus venom and the purified protein caused depolarization which was prevented by D-tubocurarine (14.6mM). The venom produced a slight increase in the amplitude and frequency of miniature end-plate potentials, but this effect was not seen with the purified fraction. These results suggest that the purified protein acts exclusively post-synaptically.
Subject(s)
Bothrops , Crotalid Venoms/pharmacology , Neuromuscular Blocking Agents/pharmacology , Neuromuscular Junction/drug effects , Peptide Hydrolases/pharmacology , Animals , Caseins/metabolism , Chickens , Chromatography, Gel , Chromatography, Ion Exchange , Crotalid Venoms/chemistry , Diaphragm/drug effects , Diaphragm/physiopathology , Electrophoresis, Polyacrylamide Gel , Male , Membrane Potentials/drug effects , Membrane Potentials/physiology , Mice , Motor Endplate/drug effects , Motor Endplate/physiopathology , Muscle Contraction/drug effects , Muscle Contraction/physiology , Neuromuscular Blockade , Neuromuscular Blocking Agents/chemistry , Neuromuscular Junction/physiopathology , Peptide Hydrolases/isolation & purification , Peptide Hydrolases/metabolismABSTRACT
The plasminogen activator isolated from the venom of the snake Trimeresurus stejnegeri (TSV-PA) triggers plasmin production, along with tissue-type plasminogen activators (t-PA) and urokinase (u-PA). The half-life of TSV-PA in plasma is remarkable. We unveil in this paper two of the molecular mechanisms allowing TSV-PA to escape inhibition by plasma serpins. The first involves a phenylalanine at position 193 (chymotrypsinogen numbering system). Phe(193) distinguishes TSV-PA from nearly all trypsin-like proteinases, having glycine at this position. A mutant of TSV-PA (F193G), in which Phe(193) had been replaced by a glycine, was inactivated by plasminogen activator inhibitor 1 (PAI-1) and alpha(2)-antiplasmin 100-fold more rapidly than the wild-type enzyme. The second mechanism originates from the 37-loop of TSV-PA. Swapping the 37-loop of TSV-PA for either that of t-PA or that of u-PA also increased dramatically the rate of inactivation by PAI-1. Loop swapping and F193G mutations were additive, resulting in a rate of inactivation by PAI-1 that was 4 orders of magnitude higher than for the wild-type enzyme. The potential role of Phe(193) and of the 37-loop in the immunity of TSV-PA toward alpha(1)-antitrypsin and antithrombin is also discussed.
Subject(s)
Plasminogen Activators/antagonists & inhibitors , Serpins/pharmacology , Amino Acid Sequence , Animals , Antithrombins/metabolism , Binding Sites , Humans , Kinetics , Molecular Sequence Data , Plasminogen Activators/chemistry , Plasminogen Activators/genetics , Recombinant Proteins/antagonists & inhibitors , Recombinant Proteins/chemistry , Thrombin/metabolism , TrimeresurusABSTRACT
Crotoxin (CACB complex) is a convulsant heterodimeric neurotoxic phospholipase A(2) (PLA(2)). The role of phospholipid hydrolysis in its epileptogenic properties remains unresolved. We, thus, studied the effect of manoalide (MLD), a PLA(2) inhibitor, on the toxin catalytic activity and its central and peripheral toxicity. Incubation of crotoxin with MLD fully and irreversibly inactivated its enzymatic activity. Interestingly, crotoxin also lost its central neurotoxicity after intracerebroventricular injection and peripheral toxicity after intravenous administration. MLD-treated crotoxin prevented the high affinity binding of [125I]-radiolabeled crotoxin on rat cortex synaptic plasma membranes. Further analysis of MLD-treated crotoxin by non-denaturing PAGE and surface plasmon resonance indicated that the crotoxin complex was dissociated after MLD treatment. Although the loss of MLD-treated crotoxin peripheral neurotoxicity could not be attributed to this dissociation, the presence of free CA subunit might explain the observed competition in binding experiments. In conclusion, the dissociation of the crotoxin complex by MLD, as demonstrated in this study, did not permit to specify the role of the enzymatic activity in crotoxin epileptogenic properties. Other approaches would be required to resolve this question.
Subject(s)
Brain/drug effects , Crotoxin/antagonists & inhibitors , Phosphodiesterase Inhibitors/pharmacology , Phospholipases A/metabolism , Terpenes/pharmacology , Animals , Brain/metabolism , Crotoxin/pharmacology , Dimerization , Drug Interactions , Hydrolysis , Iodine Radioisotopes , Male , Neurotoxicity Syndromes , Phospholipases A/antagonists & inhibitors , Phospholipids/metabolism , Rats , Rats, Wistar , Seizures/prevention & controlABSTRACT
Platelet endothelial cell adhesion molecule-1 (PECAM-1/CD31) is a 130-kd transmembrane glycoprotein and a member of the growing family of receptors with immunoreceptor tyrosine-based inhibitory motifs (ITIMs). PECAM-1 is expressed on platelets, certain T cells, monocytes, neutrophils, and vascular endothelial cells and is involved in a range of cellular processes, though the role of PECAM-1 in platelets is unclear. Cross-linking of PECAM-1 results in phosphorylation of the ITIM allowing the recruitment of signaling proteins that bind by way of Src-homology domain 2 interactions. Proteins that have been implicated in the negative regulation of cellular activation by ITIM-bearing receptors include the tyrosine phosphatases SHP-1 and SHP-2. Tyrosine phosphorylation of immunoreceptor tyrosine-based activatory motif (ITAM)-bearing receptors such as the collagen receptor GPVI-Fc receptor gamma-chain complex on platelets leads to activation. Increasing evidence suggests that ITIM- and ITAM-containing receptors may act antagonistically when expressed on the same cell. In this study it is demonstrated that cross-linking PECAM-1 inhibits the aggregation and secretion of platelets in response to collagen and the GPVI-selective agonist convulxin. In these experiments thrombin-mediated platelet aggregation and secretion were also reduced, albeit to a lesser degree than for collagen, suggesting that PECAM-1 function may not be restricted to the inhibition of ITAM-containing receptor pathways. PECAM-1 activation also inhibited platelet protein tyrosine phosphorylation stimulated by convulxin and thrombin; this was accompanied by inhibition of the mobilization of calcium from intracellular stores. These data suggest that PECAM-1 may play a role in the regulation of platelet function in vivo.
Subject(s)
Lectins, C-Type , Platelet Activation , Platelet Endothelial Cell Adhesion Molecule-1/metabolism , Signal Transduction , Antibodies/pharmacology , Binding Sites , Blood Platelets/chemistry , Blood Platelets/ultrastructure , Calcium/metabolism , Collagen/pharmacology , Cross-Linking Reagents , Crotalid Venoms/pharmacology , Cytoplasmic Granules/metabolism , Electrophoresis, Polyacrylamide Gel , Humans , Immunoglobulin Fab Fragments/pharmacology , Immunoglobulin G/pharmacology , Phosphorylation , Phosphotyrosine/metabolism , Platelet Activation/drug effects , Platelet Endothelial Cell Adhesion Molecule-1/chemistry , Thrombin/pharmacologyABSTRACT
La crotoxina, el mayor componente tóxico del veneno de serpiente cascabel sudamericana Crotalus durissus terrificus, es una fosolipasa A2 neurotóxica que ejerce su acción bloqueando la transmisión neuromuscular. Actúa primariamente alterando la liberación de acetilcolina de las terminales nerviosas mediante un mecanismo todavía no elucidado. Actúa también en membranas postsinápticas estabilizando el receptor de acetilcolina en una configuración inactiva semejante al estado de desensibilización. La crotoxina comprende dos subnuidades distintas: una fosoflipasa A2 básica y débilmente tóxica (componente B) y una acídica y no tóxica (componente A) que no posee actividad enzimática. La subunidad de fosfolipasa A2 se une en forma inespecífica y no saturable a membranas biológicas, mientras que en presencia delo componente A interacciona solamente con un limitado número de sitios de unión de alta afinidad presentes en membranas sinápticas pero no en eritrocitos. Experimentos de unión realizados con vesículas fosfolipídicas unilamelares de diferente composición indicaron que algunos de los fosfolípidos cargados negativamente, como los mono y difosfoinositósidos, podrían ser parte del sitio aceptor de crotoxina. La crotoxina es en realidad una mexcla de diversas isoformas de estructura peptídica similar pero no idéntica. Estas isoformas difieren levemente en su actividad enzimática y farmacológica. Estudios realizados con anticuerpos policonales preparados contra ambas subunidades anticomponente B (Fab) inhiben la actividad fosfolipasa A2 y neutralizan la potencia letal, lo que sugiere que los sitios tóxicos y catalíticos de la crotoxina están relacionados
Subject(s)
Crotoxin , Neuromuscular Junction/physiology , Phospholipases A/metabolism , Synaptic Transmission/drug effects , Molecular StructureABSTRACT
La crotoxina, el mayor componente tóxico del veneno de serpiente cascabel sudamericana Crotalus durissus terrificus, es una fosolipasa A2 neurotóxica que ejerce su acción bloqueando la transmisión neuromuscular. Actúa primariamente alterando la liberación de acetilcolina de las terminales nerviosas mediante un mecanismo todavía no elucidado. Actúa también en membranas postsinápticas estabilizando el receptor de acetilcolina en una configuración inactiva semejante al estado de desensibilización. La crotoxina comprende dos subnuidades distintas: una fosoflipasa A2 básica y débilmente tóxica (componente B) y una acídica y no tóxica (componente A) que no posee actividad enzimática. La subunidad de fosfolipasa A2 se une en forma inespecífica y no saturable a membranas biológicas, mientras que en presencia delo componente A interacciona solamente con un limitado número de sitios de unión de alta afinidad presentes en membranas sinápticas pero no en eritrocitos. Experimentos de unión realizados con vesículas fosfolipídicas unilamelares de diferente composición indicaron que algunos de los fosfolípidos cargados negativamente, como los mono y difosfoinositósidos, podrían ser parte del sitio aceptor de crotoxina. La crotoxina es en realidad una mexcla de diversas isoformas de estructura peptídica similar pero no idéntica. Estas isoformas difieren levemente en su actividad enzimática y farmacológica. Estudios realizados con anticuerpos policonales preparados contra ambas subunidades anticomponente B (Fab) inhiben la actividad fosfolipasa A2 y neutralizan la potencia letal, lo que sugiere que los sitios tóxicos y catalíticos de la crotoxina están relacionados (AU)